<DOC>
	<DOCNO>NCT01587118</DOCNO>
	<brief_summary>This open-label pilot study adjunctive asenapine treatment Posttraumatic Stress Disorder ( PTSD ) veterans fully remit adequate trial standard antidepressant treatment .</brief_summary>
	<brief_title>An Open Label Pilot Study Adjunctive Asenapine Treatment Posttraumatic Stress Disorder</brief_title>
	<detailed_description>Consenting Veterans diagnosis PTSD fully remit adequate trial standard antidepressant treatment ( sertraline , citalopram , escitalopram , fluoxetine , venlafaxine , mirtazapine ) treat addition open-label asenapine 12-weeks .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Asenapine</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Signed date informed consent acceptable proof identity . Male female subject â‰¥19 65 year age race ethnic origin . Not currently pregnant , breastfeed plan become pregnant ; use contraception follow : Males sexually active must use double barrier method contraception ( condom spermicide ) first dose asenapine 12 week last dose asenapine Women childbearing potential must negative urine pregnancy test confirm ( investigator ) use highly effective form birth control 3 month enrollment 12 week last dose asenapine . Women nonchild bear potential woman either permanently sterilize ( hysterectomy , bilateral oophorectomy bilateral salpingectomy exclude bilateral tubal occlusion ) postmenopausal . Diagnosis PTSD ( DSMIVTR criterion ; confirm MINI CAPS ) . Total CAPS score &gt; 45 . Currently take approve antidepressant acceptable dose 8 week nonremission symptom . No substance use disorder dependence ( except nicotine , caffeine ) previous 4 wks . No substance use disorder abuse ( except nicotine caffeine ) previous 2 wks . Physical laboratory panel ( within past one year ) within normal limit clinically significant Lifetime history bipolar I , schizophrenia , schizoaffective cognitive disorder ( assessed MINI ) Actively consider plan suicide homicide ( assessed clinical interview ) Psychotic symptom investigator 's opinion impair subject 's ability give inform consent A contraindication use asenapine antidepessant Intolerable side effect allergic reaction asenapine current antidepressant Women plan become pregnant breastfeed study Clinically significant unstable severe medical condition would contraindicate study participation expose undue risk significant adverse event , include limited : unstable severe hepatic , renal , respiratory , cardiovascular , endocrine , neurologic , hematologic disease ; hypo hyperthyroidism , unless condition stabilize ; history seizure ( except single childhood febrile seizure , posttraumatic , alcohol withdrawal ) . The following exclusionary : platelet &lt; 75,000/mm ; hemoglobin &lt; 9g/dL ; neutrophil , absolute &lt; 1000/mm ; LFTs &gt; 3x upper limit ; creatinine &gt; 2 mg/dL ; diastolic BP &lt; 60 &gt; 110mmHg ; EKG QTc &gt; 475 msec . In regard vulnerable patient population , person dementia , minor ( &lt; age 19 ) , elderly ( &gt; age 65 ) , prisoner terminally ill exclude .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>PTSD</keyword>
	<keyword>Posttraumatic Stress Disorder</keyword>
	<keyword>Asenapine</keyword>
	<keyword>Adjunctive</keyword>
	<keyword>antidepressant</keyword>
	<keyword>neuroleptic</keyword>
</DOC>